Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Published Date: 18 Oct 2024

Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High levels of traumatic stress found in caregivers of adult cancer patients

2.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

3.

When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?

4.

How Do Younger People Fare With Stool Tests for CRC Screening?

5.

Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot